ADIponectin and ADMA Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination (Amaryl-M).
Phase of Trial: Phase IV
Latest Information Update: 02 Apr 2012
At a glance
- Drugs Glimepiride/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms DIAGRAM
- Sponsors Sanofi
- 02 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jan 2012 Planned End Date changed from 1 Dec 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 09 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.